O'Shaughnessy Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-16,621	Closed	-$964K	–	1335
2019 Q2	$964K	Sell	16,621 -1,660	-9%	-$98.3K	0.02%	270
2019 Q1	$1.27M	Buy	18,281 +171	+0.9%	+$12.7K	0.03%	237
2018 Q4	$1.17M	Buy	18,110 +13,091	+261%	+$918K	0.03%	233
2018 Q3	$350K	Buy	+5,019	New	+$294K	0.01%	436

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

O'Shaughnessy Asset Management's GHDX Position: Q3 2019 in Review

O'Shaughnessy Asset Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 16,621 shares — an estimated $964K sold.

O'Shaughnessy Asset Management first reported a position in GHDX in Q3 2018 and held it in 4 quarters. The position peaked at $1.27M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

O'Shaughnessy Asset Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
O'Shaughnessy Asset Management sold 16,621 Genomic Health, Inc. shares in Q3 2019, an estimated $964K.
O'Shaughnessy Asset Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 4 quarters.
O'Shaughnessy Asset Management's Genomic Health, Inc. position peaked at $1.27M in Q1 2019.
221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.